EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Significance of Albumin in Modern Left Ventricular Assist Device Therapy: Relevance in the HeartMate 3 Era?

Roxana Moayedifar iD, Muhammed Celik iD, Barbara Karner, Anne-Kristin Schaefer iD, Hebe Al Asadi, Christiane Marko, Lukas Ruoff iD, Daniel Zimpfer iD, Julia Riebandt iD, Thomas Schlöglhofer iD

Journal of Clinical Medicine · 02.09.2025 · 14 (17) · 6193

DOI: 10.3390/jcm14176193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 02.09.2025. Verfasst von Roxana Moayedifar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac and Aortic Thoracic Surgery, Medical University Vienna, 1090 Vienna, Austria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Preoperative hypoalbuminemia is a known risk factor for adverse outcomes in cardiac surgery, but its role in patients undergoing HeartMate 3 (HM3) left ventricular assist device (LVAD) implantation is unclear. This study evaluated the association between albumin levels and postoperative outcomes, aiming to define a clinically meaningful cut-off for risk stratification. Methods: We retrospectively analyzed 205 adult patients who underwent HM3 implantation at a single center from June 2014 to December 2023. Receiver operating characteristic (ROC) analysis identified an optimal pre-implant albumin cut-off of

Schlagwörter

Stichwörter der Autor:innen

HeartMate 3biomarkerleft ventricular assist devicemechanical circulatory supportrisk factor

Autor:innen und Institutionen

  • Department of Cardiac and Aortic Thoracic Surgery, Medical University Vienna, 1090 Vienna, Austria.
  • Center for Medical Physics and Biomedical Engineering, Medical University Vienna, 1090 Vienna, Austria.
  • Ludwig Boltzmann Institute for Cardiovascular Research, 1090 Vienna, Austria.

ORCID-Profile: Roxana Moayedifar, Muhammed Celik, Anne-Kristin Schaefer, Lukas Ruoff, Daniel Zimpfer, Julia Riebandt, Thomas Schlöglhofer

Zitieren

APA

Moayedifar, R., Celik, M., Karner, B., Schaefer, A. K., Al Asadi, H., Marko, C., Ruoff, L., Zimpfer, D., Riebandt, J., & Schlöglhofer, T. (2025). Prognostic Significance of Albumin in Modern Left Ventricular Assist Device Therapy: Relevance in the HeartMate 3 Era?. Journal of Clinical Medicine, 14(17), 6193. https://doi.org/10.3390/jcm14176193

Vancouver

Moayedifar R, Celik M, Karner B, Schaefer AK, Al Asadi H, Marko C, et al. Prognostic Significance of Albumin in Modern Left Ventricular Assist Device Therapy: Relevance in the HeartMate 3 Era?. Journal of Clinical Medicine. 2025;14(17):6193. doi:10.3390/jcm14176193

BibTeX
@article{Moayedifar2025,
  author = {Moayedifar, Roxana and Celik, Muhammed and Karner, Barbara and Schaefer, Anne-Kristin and Al Asadi, Hebe and Marko, Christiane and Ruoff, Lukas and Zimpfer, Daniel and Riebandt, Julia and Schlöglhofer, Thomas},
  title = {Prognostic Significance of Albumin in Modern Left Ventricular Assist Device Therapy: Relevance in the HeartMate 3 Era?},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {17},
  pages = {6193},
  doi = {10.3390/jcm14176193}
}
Kostenlos starten →